ADCT News and Press, ADC Therapeutics SA

£90m ($114m) series A co-led by new leading life science investors Novo Holdings and Abingworth Additional new investors British Patient Capital, Cancer Research Horizons and Lilly participated alongside founding investors Brandon Capital and Sofinnova Partners Funds will be used to ...

2024-06-27 07:49:07 ET More on ADC Therapeutics Limiting Concerns On ADC Therapeutics' Prospects ADC Therapeutics down 7% following new corporate presentation ADC Therapeutics gains after data for lymphoma therapy Read the full article on Seeking Alpha ...

LAUSANNE, Switzerland, June 27, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that the Company is set to join the Russell 2000 ® Index and the broad-market Russell 3000 ® Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, ef...

2024-06-13 14:31:05 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Fundamentally, biotech stocks to buy operate on a clear and unavoidable narrative: wealth means nothing without health. You hear various stories about extremely wealthy tycoons throwing all...

2024-06-06 09:02:29 ET Summary ADC Therapeutics is developing antibody-drug conjugates for hematologic cancers and solid tumors. Their drug Zynlonta shows promise in targeting and killing cancer cells while reducing damage to healthy tissues. ADCT's pipeline includes ADCT-601 ...

LAUSANNE, Switzerland, May 30, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will present a company overview at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 11:30 a.m. ET. A live webcast of th...

LAUSANNE, Switzerland, May 15, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ on Monday, May 20, 2024 at 2:00 p.m. ...

2024-05-14 13:21:15 ET More on ADC Therapeutics ADC Therapeutics: Real Opportunity With Real Risk In 2024 (Rating Upgrade) ADC Therapeutics gains after data for lymphoma therapy ADC Therapeutics SA (ADCT) Q1 2024 Earnings Call Transcript ADC Therapeutics SA 2...

LAUSANNE, Switzerland, May 09, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the 2024 RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024, at 1:35 p.m. ET. A ...

2024-05-06 11:04:07 ET ADC Therapeutics SA (ADCT) Q1 2024 Earnings Conference Call May 06, 2024 08:30 A.M. ET Company Participants Nicole Preiss-Riley - Executive Director, Head of Communications Ameet Mallik - CEO Kristen Herrington-Smith - Chief Commercial Offi...